|
You may have a login and password to access this site |
|
| Welcome to the CALYPSO study website !
The study is:
A Multi-National, Randomized, Phase III, GCIG Intergroup Study
Comparing Pegylated
Liposomal Doxorubicin (CAELYX®) and Carboplatin vs. Paclitaxel and Carboplatin
in Patients
with Epithelial Ovarian Cancer in Late Relapse (>6 months)
that is coordinated in France by the GINECO group, a member of the GCIG
(Gynecological Cancer Intergroup). For more information on this study you may
contact the GINECO group by sending an email at
info@calypso-study.org.
The efficacy results of the CALYPSO trial presented at the 2009 meetings are now available. Please click on each logo to download the presentations.
| Analysis |
Meeting |
Presenter |
Date |
Efficacy analysis
in Relapsed, Platinum-sensitive
Ovarian Cancer |
ASCO - Orlando
(May 30th May-Jun. 02nd 2009)
|
Eric PUJADE-LAURAINE |
May 31st 2009 |
 |
ESGO - Belgrade
(October 11-14th 2009)
|
Mark HEYWOOD |
Oct. 14th 2009 |
 |
Efficacy analysis
in Relapsed, Partially
Platinum-sensitive
Ovarian Cancer |
ESMO-ECCO - Berlin
(September 20-24th 2009)
|
Paul VASEY |
Sept. 24th 2009 |
 |
If you wish to have more information, please contact ARCAGY-GINECO.
If you wish to have more information on the GCIG, you may access their website at
http://www.gcig.igcs.org/
|
| Attention: The
following applications are needed to view this website correctly.
|
• Internet Explorer 6.0 or above
or Firefox 1.0.7 or above
|
• Acrobat Reader Pluggin
|
|
|
|
|
